Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

HeartBeam Q4 2023 GAAP EPS $(0.13), Inline

Author: Benzinga Newsdesk | March 20, 2024 04:14pm
HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.13) per share which met the analyst consensus estimate.

Posted In: BEAT